Drug
Ferric citrate clinical trials
Also written KRX-0502.
- studies test it
- 19
- open now
- 2
- in phase 3
- 11
- first study started
- 2008
Keep track of what changes. Save the ferric citrate studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Name
Development codes
Studies by the year they started
19 studies that test it; most in 2017 (3)
| Year | Studies |
|---|---|
| 2008 | 1 |
| 2010 | 2 |
| 2012 | 2 |
| 2014 | 1 |
| 2015 | 2 |
| 2016 | 1 |
| 2017 | 3 |
| 2019 | 2 |
| 2020 | 1 |
| 2022 | 2 |
| 2025 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 2
- 3
- Phase 3
- 11
- Phase 4
- 4
- No phase
- 1
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 12 · Other 7
Keryx Biopharmaceuticals (7) · Panion & BF Biotech Inc. (4) · Sreedhar Mandayam (1) · Sinomune Pharmaceutical Co., Ltd (1) · Kaiser Permanente (1) · University of Alabama at Birmingham (1) · Denver Nephrologists, P.C. (1) · Dhaka Medical College (1)
Studies
Open first, then newest update. How each study uses ferric citrate is read from its arms, and is right about nine times in ten.
Testing it · 19
- Ferric Citrate in Iron Deficiency Anemia During PregnancyRecruitingPhase 3Dhaka Medical CollegeNCT07381426Written as Ferric citrate 210 mg
- Ferric Citrate and Chronic Kidney Disease in ChildrenRecruitingPhase 2University of California, Los AngelesNCT04741646Written as Ferric Citrate
- Study to Evaluate the Safety and Tolerability of Ferric Citrate in Children With Hyperphosphatemia Related to Chronic Kidney DiseaseSuspendedPhase 3Keryx BiopharmaceuticalsNCT04523727Written as ferric citrate
- Study to Evaluate the Safety and Tolerability of KRX-0502 (Ferric Citrate) in Children With Iron Deficiency Anemia Associated With Non-Dialysis Dependent Chronic Kidney DiseaseWithdrawnPhase 3Keryx BiopharmaceuticalsNCT04649411Written as ferric citrate
- PBF-1681 (Ferric Citrate) for the Treatment of IDA in Patients With NDD-CKDCompletedPhase 3Panion & BF Biotech Inc.NCT04543812Written as Ferric citrate
- Ferric Citrate for the Treatment of Hyperphosphatemia in Patients With Chronic Kidney Disease Undergoing HemodialysisCompletedPhase 3Sinomune Pharmaceutical Co., LtdNCT04456803Written as Ferric citrate tablet
- A Study of Ferric Citrate to Improve Inflammation and Lipid LevelsTerminatedPhase 4Winthrop University HospitalNCT02661295Written as Ferric Citrate
- Transition to Ferric Citrate Among Hemodialysis and Peritoneal Dialysis PatientsCompletedPhase 4Kaiser PermanenteNCT03079869Written as Ferric Citrate
- Ferric Citrate for the Treatment of Hyperphosphatemia in Patients With Chronic Kidney Disease Undergoing HemodialysisCompletedPhase 3Panion & BF Biotech Inc.NCT03984760Written as Ferric Citrate
- Impact of Ferric Citrate vs Ferrous Sulfate on Iron Parameters and Hemoglobin in Individuals With CKD and Iron DeficiencyCompletedNot applicableUniversity of Alabama at BirminghamNCT02888171Written as ferric citrate
- Assess the Safety and Efficacy of Nephoxil® in Subjects With End Stage Renal Disease (ESRD) on DialysisCompletedPhase 4Panion & BF Biotech Inc.NCT03256838Written as Ferric Citrate
- A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of the Effects of Ferric Citrate in Subjects With End Stage Renal DiseaseCompletedPhase 3Panion & BF Biotech Inc.NCT01503736Written as ferric citrate
- Ferric Citrate in ESRD Pilot ProjectActive, not recruitingPhase 4Sreedhar MandayamNCT03055598Written as Ferric Citrate
- Ferric Citrate for the Transition From CKD Stage 4/5 to CKD Stage 5DCompletedPhase 3Denver Nephrologists, P.C.NCT02492620Written as Ferric Citrate
- KRX-0502 (Ferric Citrate) for the Treatment of IDA in Adult Subjects With NDD-CKDCompletedPhase 3Keryx BiopharmaceuticalsNCT02268994Written as ferric citrate
- Ferric Citrate in Managing Serum Phosphorus and Iron Deficiency in Anemic Chronic Kidney Disease (CKD) Subjects Not on DialysisCompletedPhase 2Keryx BiopharmaceuticalsNCT01736397Written as Ferric Citrate
- A Safety and Tolerability Study of Zerenex (Ferric Citrate) in Patients With End-Stage Renal Disease (ESRD)CompletedPhase 2Keryx BiopharmaceuticalsNCT00648167Written as ferric citrate
- A Long-Term Safety Extension Trial of Ferric Citrate in Patients With End-Stage Renal Disease (ESRD) on DialysisCompletedPhase 3Keryx BiopharmaceuticalsNCT01554982Written as ferric citrate
- A 4-Week Dose-Ranging and Efficacy Trial of KRX-0502 (Ferric Citrate) in Patients With End-Stage Renal DiseaseCompletedPhase 3Keryx BiopharmaceuticalsNCT01074125Written as ferric citrate
Codes
What other systems call ferric citrate · ClinicalTrials.gg INT002810
- MeSH (NLM) C025314ferric citrateConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) 63G354M39ZFERRIC CITRATE ANHYDROUSOne source NLM
- RxNorm 1594675One source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C025314 | ferric citrate | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | 63G354M39Z | FERRIC CITRATE ANHYDROUS | One source NLM |
| RxNorm | 1594675 | — | One source FDA |
Also registered as ferric citrate dihydrate (UNII R6V6N63VUJ) and ferric citrate trihydrate (UNII 756B6D74H4).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.